(Q68018205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

0 references

1 reference

title

The beta-agonist controversy: fact or fiction? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

author name string

B J Lipworth

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

publication date

1 July 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Allergy

20 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

659-664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

20 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Comparison of the bronchodilator and cardiovascular actions of isoprenaline, Th 1165a, terbutaline and salbutamol in cats and isolated organ preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on β-adrenoceptors in guinea-pig trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

An examination of some -adrenoreceptor stimulants for selectivity using the isolated trachea and atria of the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

β-Adrenoceptors of the human myocardium: determination of β1 and β2 subtypes by radioligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Effects of the beta 2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Beta-adrenoceptor responses to inhaled salbutamol in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Effect of prednisolone and ketotifen on beta 2-adrenoceptors in asthmatic patients receiving beta 2-bronchodilators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Effects of low potassium or magnesium concentrations on isolated cardiac tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Further observations on the cardiotoxicity of isoprenaline during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Prolonged Protection against Methacholine-induced Bronchoconstriction by the Inhaled β2-Agonist Formoterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Protection against allergen-induced asthma by salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB00187.X

10.1111/J.1365-2222.1992.TB00187.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1504886%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference